Skip to main content
T-Minus ZeroComm Link
Artemis Hub logo

Contract Story

ASST_NON_R43GM159517_075|

FULLY AUTONOMOUS ROBOTIC WET LAB FOR STEM CELL CULTURE MEDIA OPTIMIZATION - PROJECT SUMMARY HEMATOPOIETIC STEM CELLS (HSCS) ARE PERHAPS THE MOST IMPORTANT AND IMMEDIATELY ACTIONABLE CELLS FOR CELL REJUVENATION THERAPIES, BUT THE DIFFICULTY OF GROWING THEM IN THE LAB LIMITS THEIR POTENTIAL. TO ADDRESS THIS PROBLEM, WE ARE USING A FULLY AUTONOMOUS, ML-DRIVEN WET LAB TO OPTIMIZE HSC CULTURE MEDIA. OUR SYSTEM, WHICH WE REFER TO AS A “MACHINE BIOLOGIST”, HAS TWO MAJOR COMPONENTS: THE “BODY”, CONSISTING OF A ROBOTIC WET LAB CAPABLE OF PERFORMING HSC CULTURE EXPERIMENTS, AND THE “MIND”, CONSISTING OF AN MACHINE LEARNED (ML) COMPUTER VISION MODEL FOR ANALYZING OUR MICROSCOPY RESULTS AND A BAYESIAN OPTIMIZER TO PERFORM EXPERIMENTAL DESIGN. THIS COMBINATION WILL ALLOW OUR SYSTEM TO OPERATE FULLY AUTONOMOUSLY, AND PROCEED ORDERS-OF-MAGNITUDE FASTER THAN IS POSSIBLE IN A CONVENTIONAL BIOLOGY LAB. OUR WORK HAS THE POTENTIAL FOR TRANSFORMATIVE IMPACT ON BOTH THE WAY CELL BIOLOGY RESEARCH IS CONDUCTED AS WELL AS HSC-BASED CELL THERAPIES.

PIID: ASST_NON_R43GM159517_075Mission: programFamily size: 1Actions: 1Notices: 0Bidders: 0

Contract Family

  • ASST_NON_R43GM159517_075|

    Awardee: DRAGONASE LLC · Base award: Jun 01, 2025

    unknown

    FULLY AUTONOMOUS ROBOTIC WET LAB FOR STEM CELL CULTURE MEDIA OPTIMIZATION - PROJECT SUMMARY HEMATOPOIETIC STEM CELLS (HSCS) ARE PERHAPS THE MOST IMPORTANT AND IMMEDIATELY ACTIONABLE CELLS FOR CELL REJUVENATION THERAPIES, BUT THE DIFFICULTY OF GROWING THEM IN THE LAB LIMITS THEIR POTENTIAL. TO ADDRESS THIS PROBLEM, WE ARE USING A FULLY AUTONOMOUS, ML-DRIVEN WET LAB TO OPTIMIZE HSC CULTURE MEDIA. OUR SYSTEM, WHICH WE REFER TO AS A “MACHINE BIOLOGIST”, HAS TWO MAJOR COMPONENTS: THE “BODY”, CONSISTING OF A ROBOTIC WET LAB CAPABLE OF PERFORMING HSC CULTURE EXPERIMENTS, AND THE “MIND”, CONSISTING OF AN MACHINE LEARNED (ML) COMPUTER VISION MODEL FOR ANALYZING OUR MICROSCOPY RESULTS AND A BAYESIAN OPTIMIZER TO PERFORM EXPERIMENTAL DESIGN. THIS COMBINATION WILL ALLOW OUR SYSTEM TO OPERATE FULLY AUTONOMOUSLY, AND PROCEED ORDERS-OF-MAGNITUDE FASTER THAN IS POSSIBLE IN A CONVENTIONAL BIOLOGY LAB. OUR WORK HAS THE POTENTIAL FOR TRANSFORMATIVE IMPACT ON BOTH THE WAY CELL BIOLOGY RESEARCH IS CONDUCTED AS WELL AS HSC-BASED CELL THERAPIES.

    Parent award:
    n/a
    Referenced IDV:
    n/a
    Agency code:
    n/a
    Subtier code:
    8000

Action Timeline

  • Mod 02025-06-01

    Delta: $350,000 • Cumulative: N/A

    Source: usaspending

Opportunity & Bidding Signals

Who is or was on the solicitation thread, with opportunity notices and awardee names.

No notices are currently linked to this PIID.

Funding Trend

First action: Jun 01, 2025Latest action: Jun 01, 2025Total obligations points: 1
  • FY 2025 M09usaspending

    Obligations: $350,000 • Outlays: N/A